Dermatologist Skin Care For People With Eczema

Eczema Clinic

Hydromol Bath and Shower Emollient 500 Ml

Regular Price
£12.16
Sale Price
£12.16
Regular Price
£0.00
Sold Out
Unit Price
per 

    Product Description

    Hydromol Bath and Shower Emollient, 500ml 

    Why We Chose This Product

    • Bath oils have been shown to reduce dryness in the skin (although a large study in 2018 showed that they didn't reduce eczema severity overall).  
    • Hydromol can be used in the bath or shower.
    • Hydromol disperses easily in the water without leaving residue.
    • It is soap free 
    • It is suitable for all ages: adults, children and babies.
    • It contains no fragrances or colourings or preservatives, so it is less likely to cause an allergic reaction to the skin. 
    • The main ingredient is paraffin. Paraffin is useful in eczema, as paraffin is not an allergic material.  

    Ingredients

    Light liquid paraffin, Isopropyl myristrate, C12-C14 Alcohol with 3 molecules of ethylene Oxidate (Fatty alcohol ethoxylate), Polyol Fatty Acid Ester, Iso-octyl stearate.

    Cautions

    • Use of bath oils in the bath can or shower be a slip hazard
    • Bath oils are flammable.   

    Directions

    1) Bath: Add 1-3 capfuls to 20cm of bath water and soak for 10-15 minutes 2) Shower: Pour a small amount onto a wet sponger or flannel and gently rub into wet skin. 3) Rinse and pat dry when finished.

    References

    1. Kottner J, Kanti V, Dobos G, Hahnel E, Lichterfeld-Kottner A, Richter C, Hillmann K, Vogt A, Blume-Peytavi U. The effectiveness of using a bath oil to reduce signs of dry skin: A randomized controlled pragmatic study. Int J Nurs Stud. 2017 Jan;65:17-24. doi: 10.1016/j.ijnurstu.2016.10.010. Epub 2016 Oct 26. PMID: 27815985.

    2. Santer M, Ridd MJ, Francis NA, Stuart B, Rumsby K, Chorozoglou M, Becque T, Roberts A, Liddiard L, Nollett C, Hooper J, Prude M, Wood W, Thomas KS, Thomas-Jones E, Williams HC, Little P. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness. BMJ. 2018 May 3;361:k1332. doi: 10.1136/bmj.k1332. PMID: 29724749; PMCID: PMC5930266.